查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600610

臨床試驗用品市場：按階段、類型、產品、治療領域和最終用戶 - 2025-2030 年全球預測

Clinical Trial Supplies Market by Phase (Phase I, Phase II, Phase III), Type (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年臨床試驗耗材市場規模為33.5億美元，預計2024年將達36.4億美元，複合年成長率為8.43%，預計2030年將達59.2億美元。

臨床試驗用品市場包括進行臨床試驗所需的用品的製造、包裝、標籤和分銷，例如藥品、醫療設備和其他與試驗相關的材料。對這些物資的主要需求是促進對新療法的嚴格測試，以確保其在到達患者手中之前的安全性和有效性。應用範圍橫跨製藥、生技、醫療設備等生命科學領域，目標使用者為大型製藥公司、科研院所、學術機構等。推動市場成長的關鍵因素包括慢性病的增加、生物技術的進步以及強勁的研發投資推動的臨床試驗的增加。此外，臨床試驗的全球化需要高效率的供應鏈策略，進一步推動市場擴張。最近的趨勢，包括因 COVID-19 大流行而導致的技術整合以及臨床試驗的分散化和虛擬化，提供了潛在的商機。公司可以透過投資創新的數位工具來利用這些工具，例如用於透明度的區塊鏈和用於物流最佳化的人工智慧。然而，嚴格的監管要求、高成本和供應鏈複雜性等挑戰限制了成長。解決這些問題需要策略重點關注監管合規性和成本效率。低溫運輸物流、適應性試驗設計和個人化醫療的創新可以進一步加速成長。為此，公司必須尋求先進的追蹤系統和強大的雲端基礎的解決方案，以提高供應的安全性。市場的特點是競爭激烈、技術進步迅速，需要敏捷性和持續創新。整體而言，尋求發展的公司不僅必須透過全面的合規策略和先進的物流框架來應對這些挑戰，還必須採用保證效率和可靠性的新技術。我們對這些領域的關注使我們能夠滿足臨床試驗不斷變化的需求，並在保持競爭力的同時利用商業機會。

主要市場統計
基準年[2023] 33.5億美元
預測年份 [2024] 36.4億美元
預測年份 [2030] 59.2億美元
複合年成長率（%） 8.43%

市場動態：揭示快速發展的臨床試驗用品市場的關鍵市場洞察

供需的動態交互作用正在改變臨床試驗用品市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球感染疾病和慢性病盛行率增加
    • 製藥和生物製藥產業研發支出增加
  • 市場限制因素
    • 臨床試驗耗材高成本
  • 市場機會
    • 重視藥物開發並轉向以病人為中心的臨床試驗
    • 多樣化臨床試驗用品的持續進步
  • 市場挑戰
    • 臨床試驗用品嚴格監管

波特的五力策略工具駕馭臨床試驗用品市場

波特的五力架構是了解臨床試驗用品市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解臨床試驗用品市場的外部影響

外部宏觀環境因素在塑造臨床試驗用品市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解臨床試驗用品市場的競爭狀況

臨床試驗用品市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣臨床試驗用品市場供應商的績效評估

FPNV定位矩陣是評估臨床試驗用品市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地感染疾病和慢性病的盛行率正在增加。
      • 加大製藥和生物製藥產業的研發力度
    • 抑制因素
      • 臨床試驗耗材成本高
    • 機會
      • 重視藥物開發並轉向以病人為中心的臨床試驗
      • 多樣化臨床試驗用品的持續進步
    • 任務
      • 臨床試驗用品嚴格監管
  • 市場區隔分析
    • 階段：為了做出有關臨床試驗的最佳決策，對臨床試驗用品的需求逐階段增加。
    • 類型：慢性病治療方法突破，生物藥需求快速成長
    • 產品：輔助藥物是臨床試驗的關鍵組成部分，因為它們對於確保研究的安全性和整體效率至關重要。
    • 治療領域：全球感染疾病負擔增加，臨床試驗用品需求增加
    • 最終用戶：研發活動外包的增加增加了 CRO 中臨床試驗用品的使用。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 臨床試驗用品市場分階段狀況

  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第7章 臨床試驗用品市場：依類型

  • 生物製藥
  • 醫療設備
  • 小分子

第8章臨床試驗用品市場：依產品

  • 補充藥物
  • 互動式響應技術（IRT）解決方案
  • 實驗室用品
    • 離心機
    • 顯微鏡
    • 移液器
    • 試劑
  • 醫療設備和診斷
  • 藥局用品
    • 生物危害袋
    • 複合無菌隔離器
    • 消毒器
  • 研究資料
  • 安全設備

第9章依治療領域分類的臨床試驗用品市場

  • 心臟病學
  • 遺傳疾病
  • 免疫學
  • 感染疾病
  • 代謝紊亂
  • 神經病學
  • 腫瘤學

第10章臨床試驗用品市場：依最終使用者分類

  • 合約調查機構
  • 製藥和生物技術公司

第11章 北美和南美臨床試驗用品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太臨床試驗用品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東、非洲臨床試驗用品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 訊號：英國臨床研究提供商 Ergomed 將以 8.88 億美元收購
    • 賽默飛世爾科技推出全新智慧冰箱系列
    • Loftware 和 Tenthpin 合作開發臨床供應標籤
    • Sitero 收購 Clario 的 eClinical 技術套件以增強臨床試驗執行
    • Replimune 和 Insight 簽署臨床試驗合作和供應協議，以評估 RP1 和 INCB99280 在皮膚鱗狀細胞癌患者中的應用
    • BD 推出新型機器人系統以實現臨床流式細胞技術自動化
    • Lonza 收購 Synafix 以加強抗體藥物複合體產品
    • IDEAYA 擴大了與輝瑞的臨床試驗合作和供應協議，以支持一項評估 Darovasertib 和 Crizotinib 組合用於轉移性葡萄膜黑色素瘤一線治療的註冊試驗。
    • Plus Therapeutics 擴大與 Piramal Pharma Solutions 的合作關係，以滿足正在進行和計劃的臨床試驗中對臨床實驗藥物日益成長的需求
    • 西門子 Healthineers 在索茲開設實驗設備研發中心
    • Experic完成1,400萬美元B輪資金籌措
    • Medline 額外投資 5 億美元用於醫療用品庫存，以增強產品可用性

公司名單

  • Johnson & Johnson Services, Inc.
  • Bruker Corporation
  • Cardinal Health, Inc.
  • Rubicon Research Pvt. Ltd.
  • Sharp Services, LLC
  • Emsere BV by Medicapital Holdco BV
  • Medline Industries, LP
  • Thermo Fisher Scientific Inc.
  • Novo Nordisk A/S
  • Evident Corporation by Olympus Corporation
  • KLIFO A/S
  • Merck KGaA
  • Almac Group Limited
  • Woodley Equipment Company Ltd.
  • Lonza Group Ltd.
  • Pfizer Inc.
  • Leica Microsystems GmbH by Danaher Corporation
  • Myonex, LLC
  • Becton, Dickinson and Company
  • Stryker Corporation
  • Promega Corporation
  • Nuvisan GmbH
  • Incyte Corporation
  • 3M Company
  • Recipharm AB
  • Charles River Laboratories, Inc.
  • Siemens Healthcare GmbH
  • IQVIA Inc.
  • Parexel International Corporation
  • F. Hoffmann-La Roche Ltd.
  • Bayer AG
  • HORIBA, Ltd.
  • ICON PLC
  • Bio-Rad Laboratories, Inc.
  • COREX LOGISTICS LIMITED
  • Perceptive Informatics LLC and its affiliates, d/b/a Calyx
  • Immudex ApS
  • Eppendorf SE
  • Abbott Laboratories
  • PerkinElmer Inc. by Revvity, Inc.
  • Fujifilm Group
  • Hitachi, Ltd.
  • Hipro Biotechnology Co., Ltd.
  • Labnet International
  • Baxter International, Inc.
  • B. Braun SE
  • llumina, Inc.
  • Sekisui Diagnostics Group
  • Smith & Nephew PLC
Product Code: MRR-E0619F076721

The Clinical Trial Supplies Market was valued at USD 3.35 billion in 2023, expected to reach USD 3.64 billion in 2024, and is projected to grow at a CAGR of 8.43%, to USD 5.92 billion by 2030.

The clinical trial supplies market encompasses the manufacturing, packaging, labeling, and distribution of supplies needed to conduct clinical trials, including drugs, medical devices, and other study-related materials. The primary necessity of these supplies lies in their role in facilitating rigorous testing to ensure safety and efficacy before new treatments reach patients. The application scope extends across pharmaceuticals, biotechnology, medical devices, and other life sciences sectors, targeting end-users such as pharmaceutical giants, research organizations, and academic institutions. Key factors driving market growth include increasing clinical trials propelled by rising chronic diseases, advancing biotechnology, and robust R&D investments. Moreover, the globalization of clinical trials necessitates efficient supply chain strategies, further propelling market expansion. Recent trends involving decentralized and virtual trials due to technological integration and the COVID-19 pandemic offer potential opportunities. Businesses can capitalize on these by investing in innovative digital tools, such as blockchain for transparency or AI for logistics optimization. However, challenges like stringent regulatory requirements, high costs, and supply chain complexities pose growth constraints. Navigating these demands a strategic focus on regulatory compliance and cost efficiency. Innovations in cold chain logistics, adaptive trial designs, and personalized medicine can further spurn growth. To do so, companies should explore advanced tracking systems or robust cloud-based solutions to enhance supply security. The market is characterized by high competition and rapid technological advancements, necessitating agility and continual innovation. Overall, businesses aspiring for growth need not only to address these challenges with comprehensive compliance strategies and advanced logistical frameworks but also to embrace emerging technologies that promise efficiency and reliability. Emphasizing these areas will position businesses to leverage opportunities, addressing the evolving needs of clinical trials while maintaining a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 3.35 billion
Estimated Year [2024] USD 3.64 billion
Forecast Year [2030] USD 5.92 billion
CAGR (%) 8.43%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Trial Supplies Market

The Clinical Trial Supplies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of infectious and chronic diseases worldwide
    • Rising research and development expenditure by pharmaceutical and biopharmaceutical industry
  • Market Restraints
    • High cost of clinical trial supplies
  • Market Opportunities
    • Emphasis on drug development and shift towards patient-centric clinical trials
    • Ongoing advancements in a diverse range of clinical trial supplies
  • Market Challenges
    • Stringent regulations for clinical trial supplies

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Trial Supplies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Trial Supplies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Trial Supplies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Trial Supplies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Trial Supplies Market

A detailed market share analysis in the Clinical Trial Supplies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Trial Supplies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Trial Supplies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supplies Market, highlighting leading vendors and their innovative profiles. These include Johnson & Johnson Services, Inc., Bruker Corporation, Cardinal Health, Inc., Rubicon Research Pvt. Ltd., Sharp Services, LLC, Emsere B.V by Medicapital Holdco B.V., Medline Industries, LP, Thermo Fisher Scientific Inc., Novo Nordisk A/S, Evident Corporation by Olympus Corporation, KLIFO A/S, Merck KGaA, Almac Group Limited, Woodley Equipment Company Ltd., Lonza Group Ltd., Pfizer Inc., Leica Microsystems GmbH by Danaher Corporation, Myonex, LLC, Becton, Dickinson and Company, Stryker Corporation, Promega Corporation, Nuvisan GmbH, Incyte Corporation, 3M Company, Recipharm AB, Charles River Laboratories, Inc., Siemens Healthcare GmbH, IQVIA Inc., Parexel International Corporation, F. Hoffmann-La Roche Ltd., Bayer AG, HORIBA, Ltd., ICON PLC, Bio-Rad Laboratories, Inc., COREX LOGISTICS LIMITED, Perceptive Informatics LLC and its affiliates, d/b/a Calyx, Immudex ApS, Eppendorf SE, Abbott Laboratories, PerkinElmer Inc. by Revvity, Inc., Fujifilm Group, Hitachi, Ltd., Hipro Biotechnology Co., Ltd., Labnet International, Baxter International, Inc., B. Braun SE, llumina, Inc., Sekisui Diagnostics Group, and Smith & Nephew PLC.

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supplies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Phase, market is studied across Phase I, Phase II, Phase III, and Phase IV.
  • Based on Type, market is studied across Biologic Drugs, Medical Devices, and Small-Molecules.
  • Based on Product, market is studied across Auxiliary Medicinal Products, Interactive Response Technology (IRT) solutions, Lab Supplies, Medical Devices & Diagnostics, Pharmacy Supplies, Research Materials, and Safety Equipment. The Lab Supplies is further studied across Centrifuges, Microscopes, Pipettes, and Reagents. The Pharmacy Supplies is further studied across Biohazard Bags, Compounding Aseptic Isolators, and Sterilization Equipment.
  • Based on Therapeutic Area, market is studied across Cardiology, Genetic Diseases, Immunology, Infectious Diseases, Metabolic Disorders, Neurology, and Oncology.
  • Based on End User, market is studied across Contract Research Organisations and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious and chronic diseases worldwide
      • 5.1.1.2. Rising research and development expenditure by pharmaceutical and biopharmaceutical industry
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of clinical trial supplies
    • 5.1.3. Opportunities
      • 5.1.3.1. Emphasis on drug development and shift towards patient-centric clinical trials
      • 5.1.3.2. Ongoing advancements in a diverse range of clinical trial supplies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations for clinical trial supplies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Phase: Growing demand for clinical trial supplies for each phase for optimal decision-making regarding clinical trial
    • 5.2.2. Type: Surge in biologic drugs demand with breakthrough therapies for chronic ailments
    • 5.2.3. Product: Auxiliary medicinal products are vital elements of clinical trials, owing to their significance of assuring safety, and efficiency in the overall research operation
    • 5.2.4. Therapeutic Area: Rising burden of infectious diseases worldwide create a demand for clinical trial supplies
    • 5.2.5. End User: Growing use of clinical trial supplies in CROs due to rising outsourcing of R&D activities
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Trial Supplies Market, by Phase

  • 6.1. Introduction
  • 6.2. Phase I
  • 6.3. Phase II
  • 6.4. Phase III
  • 6.5. Phase IV

7. Clinical Trial Supplies Market, by Type

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Medical Devices
  • 7.4. Small-Molecules

8. Clinical Trial Supplies Market, by Product

  • 8.1. Introduction
  • 8.2. Auxiliary Medicinal Products
  • 8.3. Interactive Response Technology (IRT) solutions
  • 8.4. Lab Supplies
    • 8.4.1. Centrifuges
    • 8.4.2. Microscopes
    • 8.4.3. Pipettes
    • 8.4.4. Reagents
  • 8.5. Medical Devices & Diagnostics
  • 8.6. Pharmacy Supplies
    • 8.6.1. Biohazard Bags
    • 8.6.2. Compounding Aseptic Isolators
    • 8.6.3. Sterilization Equipment
  • 8.7. Research Materials
  • 8.8. Safety Equipment

9. Clinical Trial Supplies Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Cardiology
  • 9.3. Genetic Diseases
  • 9.4. Immunology
  • 9.5. Infectious Diseases
  • 9.6. Metabolic Disorders
  • 9.7. Neurology
  • 9.8. Oncology

10. Clinical Trial Supplies Market, by End User

  • 10.1. Introduction
  • 10.2. Contract Research Organisations
  • 10.3. Pharmaceutical & Biotechnology Companies

11. Americas Clinical Trial Supplies Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Clinical Trial Supplies Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Supplies Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Signal: UK Clinical Research Provider Ergomed Bought Out in USD 888 Million Deal
    • 14.3.2. Thermo Fisher Scientific Launches New Smart Refrigerator Series
    • 14.3.3. Loftware and Tenthpin Collaborate on Clinical Supply Labeling
    • 14.3.4. Sitero Acquires Clario's eClinical Technology Suite to Enhance Clinical Trial Delivery
    • 14.3.5. Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma
    • 14.3.6. BD Launches New Robotic System to Automate Clinical Flow Cytometry
    • 14.3.7. Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
    • 14.3.8. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer to Support Registrational Trial Evaluating Darovasertib and Crizotinib Combination in First-Line Metastatic Uveal Melanoma
    • 14.3.9. Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials
    • 14.3.10. Siemens Healthineers Launch Laboratory Equipment R&D Centre in Swords
    • 14.3.11. Experic Closes USD 14 Million Series B Financing
    • 14.3.12. Medline Invests Additional USD 500M in Medical Supply Inventory to Boost Product Availability

Companies Mentioned

  • 1. Johnson & Johnson Services, Inc.
  • 2. Bruker Corporation
  • 3. Cardinal Health, Inc.
  • 4. Rubicon Research Pvt. Ltd.
  • 5. Sharp Services, LLC
  • 6. Emsere B.V by Medicapital Holdco B.V.
  • 7. Medline Industries, LP
  • 8. Thermo Fisher Scientific Inc.
  • 9. Novo Nordisk A/S
  • 10. Evident Corporation by Olympus Corporation
  • 11. KLIFO A/S
  • 12. Merck KGaA
  • 13. Almac Group Limited
  • 14. Woodley Equipment Company Ltd.
  • 15. Lonza Group Ltd.
  • 16. Pfizer Inc.
  • 17. Leica Microsystems GmbH by Danaher Corporation
  • 18. Myonex, LLC
  • 19. Becton, Dickinson and Company
  • 20. Stryker Corporation
  • 21. Promega Corporation
  • 22. Nuvisan GmbH
  • 23. Incyte Corporation
  • 24. 3M Company
  • 25. Recipharm AB
  • 26. Charles River Laboratories, Inc.
  • 27. Siemens Healthcare GmbH
  • 28. IQVIA Inc.
  • 29. Parexel International Corporation
  • 30. F. Hoffmann-La Roche Ltd.
  • 31. Bayer AG
  • 32. HORIBA, Ltd.
  • 33. ICON PLC
  • 34. Bio-Rad Laboratories, Inc.
  • 35. COREX LOGISTICS LIMITED
  • 36. Perceptive Informatics LLC and its affiliates, d/b/a Calyx
  • 37. Immudex ApS
  • 38. Eppendorf SE
  • 39. Abbott Laboratories
  • 40. PerkinElmer Inc. by Revvity, Inc.
  • 41. Fujifilm Group
  • 42. Hitachi, Ltd.
  • 43. Hipro Biotechnology Co., Ltd.
  • 44. Labnet International
  • 45. Baxter International, Inc.
  • 46. B. Braun SE
  • 47. llumina, Inc.
  • 48. Sekisui Diagnostics Group
  • 49. Smith & Nephew PLC

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL SUPPLIES MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL SUPPLIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CLINICAL TRIAL SUPPLIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL SUPPLIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIAL SUPPLIES MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SMALL-MOLECULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY AUXILIARY MEDICINAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT) SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PIPETTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES & DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOHAZARD BAGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COMPOUNDING ASEPTIC ISOLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RESEARCH MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SAFETY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 144. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 149. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 150. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 151. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 163. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 164. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 165. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 170. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 171. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 172. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 177. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 178. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 179. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 192. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 193. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 194. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 199. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 200. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 201. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 206. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 207. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 208. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 213. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 214. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 215. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 220. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 221. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 222. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 227. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 228. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 229. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 234. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 235. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 236. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 241. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 242. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 243. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 248. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 249. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 250. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 255. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 256. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 257. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 262. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 263. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 264. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 269. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 270. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 271. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 276. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 277. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 278. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 284. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 285. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 291. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 292. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 297. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 298. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 299. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 304. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 305. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 306. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 311. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 312. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 313. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 317. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 318. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 319. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 320. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 329. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 330. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 331. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 332. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 333. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 334. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 335. CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 336. CLINICAL TRIAL SUPPLIES MARKET, FPNV POSITIONING MATRIX, 2023